PCM
Penserra Capital Management Portfolio holdings
AUM
$7.17B
1-Year Return
49.58%
This Quarter Return
+7.91%
1 Year Return
+49.58%
3 Year Return
+118.16%
5 Year Return
+229.83%
10 Year Return
–
AUM
$5.51B
AUM Growth
+$99.7M
(+1.8%)
Cap. Flow
-$135M
Cap. Flow
% of AUM
-2.45%
Top 10 Holdings %
Top 10 Hldgs %
18.48%
Holding
1,442
New
337
Increased
638
Reduced
343
Closed
110
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
+$62.6M |
| 2 |
Pinduoduo
PDD
|
+$46.6M |
| 3 |
ThredUp
TDUP
|
+$33.9M |
| 4 |
Upwork
UPWK
|
+$30.8M |
| 5 |
LOGC
ContextLogic
LOGC
|
+$28.5M |
Top Sells
| 1 |
Revolve Group
RVLV
|
+$84.7M |
| 2 |
NetEase
NTES
|
+$53.1M |
| 3 |
QVCGA
QVC Group, Inc. Series A Common Stock
QVCGA
|
+$44.7M |
| 4 |
TripAdvisor
TRIP
|
+$41.2M |
| 5 |
Groupon
GRPN
|
+$40.8M |
Sector Composition
| 1 | Consumer Discretionary | 30.41% |
| 2 | Technology | 24.83% |
| 3 | Communication Services | 13.13% |
| 4 | Financials | 4.98% |
| 5 | Industrials | 4.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Generation Bio
GBIO
$41M
| $34K | ﹤0.01% |
129
+6
| +5% | +$1.58K |
|
1077
Krystal Biotech
KRYS
$3.98B
| $34K | ﹤0.01% |
505
+5
| +1% | +$337 |
|
1078
RLJ Lodging Trust
RLJ
$1.15B
| $34K | ﹤0.01% |
+2,266
| New | +$34K |
|
|
NGM
1079
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $34K | ﹤0.01% |
1,755
+90
| +5% | +$1.74K |
|
1080
Hyatt Hotels
H
$13.6B
| $33K | ﹤0.01% |
+429
| New | +$33K |
|
1081
Eli Lilly
LLY
$673B
| $33K | ﹤0.01% |
+145
| New | +$33K |
|
|
SVC
1082
Service Properties Trust
SVC
$471M
| $33K | ﹤0.01% |
+2,695
| New | +$33K |
|
1083
Codexis
CDXS
$224M
| $33K | ﹤0.01% |
1,470
+35
| +2% | +$786 |
|
1084
Y-mAbs Therapeutics
YMAB
$389M
| $33K | ﹤0.01% |
990
+10
| +1% | +$333 |
|
1085
Cytokinetics
CYTK
$6.11B
| $32K | ﹤0.01% |
1,635
+30
| +2% | +$587 |
|
1086
NiSource
NI
$19.2B
| $32K | ﹤0.01% |
+1,320
| New | +$32K |
|
1087
uniQure
QURE
$951M
| $32K | ﹤0.01% |
1,050
+45
| +4% | +$1.37K |
|
1088
Arcutis Biotherapeutics
ARQT
$2.12B
| $31K | ﹤0.01% |
1,145
+15
| +1% | +$406 |
|
1089
Kura Oncology
KURA
$734M
| $31K | ﹤0.01% |
1,510
+15
| +1% | +$308 |
|
1090
Skywest
SKYW
$4.39B
| $31K | ﹤0.01% |
+737
| New | +$31K |
|
1091
VF Corp
VFC
$5.9B
| $31K | ﹤0.01% |
+385
| New | +$31K |
|
|
VLRS
1092
Controladora Vuela Compañía de Aviación
VLRS
$704M
| $31K | ﹤0.01% |
+1,639
| New | +$31K |
|
1093
Amgen
AMGN
$150B
| $30K | ﹤0.01% |
125
-42,119
| -100% | -$10.1M |
|
1094
Hershey
HSY
$37.6B
| $30K | ﹤0.01% |
+175
| New | +$30K |
|
1095
MannKind Corp
MNKD
$1.68B
| $30K | ﹤0.01% |
5,670
+50
| +0.9% | +$265 |
|
1096
Precigen
PGEN
$1.18B
| $30K | ﹤0.01% |
4,700
+105
| +2% | +$670 |
|
1097
Atara Biotherapeutics
ATRA
$82.7M
| $29K | ﹤0.01% |
77
+2
| +3% | +$753 |
|
1098
Walt Disney
DIS
$208B
| $29K | ﹤0.01% |
+170
| New | +$29K |
|
1099
TJX Companies
TJX
$156B
| $29K | ﹤0.01% |
440
-5,636
| -93% | -$371K |
|
|
KLRS
1100
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.1M
| $29K | ﹤0.01% |
64
| – | – |
|